✦ LIBER ✦

Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease?

✍ Scribed by Marwan N. Sabbagh; Martin R. Farlow; Normal Relkin; Thomas G. Beach

Book ID: 118462041
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 160 KB
Volume: 2
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2006.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Have cholinergic therapies reached their

Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?

✍ Roy W. Jones 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The cholinergic hypothesis suggests that Alzheimer's disease (AD) results from a selective loss in cholinergic neurons with decreased acetylcholine levels. Treatments that increase the level of acetylcholine would be expected to provide clinical benefit. Clinical trials of dietary precursors of acet

Measuring target effect of proposed dise

Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease

✍ Randall J. Bateman; William E. Klunk 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 165 KB

54-4 - Non-cholinergic therapies for Alz

54-4 - Non-cholinergic therapies for Alzheimer's disease

✍ V. Kumar; K. Sugaya 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Cholinergic foundations of Alzheimer's d

Cholinergic foundations of Alzheimer's disease therapy

✍ Ezio Giacobini 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 434 KB

41-1 - Subtype-specific muscarinic choli

41-1 - Subtype-specific muscarinic cholinergic therapies in Alzheimer's disease

✍ A.I. Levey 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Preclinical and clinical challenges in t

Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease

✍ Carol A Scorer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB